Infant gut health Persephone has launched infant and toddler synbiotics and Gölden products focused on gut and immune health, opening direct sales opportunities to parents, pediatric clinics, and family health retailers seeking science-backed microbiome solutions.

Clinical collaboration Past and ongoing partnerships with Kroger Health, Janssen Biotech, and Ginkgo Bioworks indicate a readiness to collaborate on clinical studies and real-world evidence, suggesting channels for co-marketing, pilot programs, and joint research-driven product expansions.

Expanded accessibility Availability of synbiotics on Amazon demonstrates retail accessibility; this creates upsell and cross-sell opportunities with consumer health channels, pediatricians, and microbiome-focused education campaigns aligned with e-commerce.

Microbiome toolkit The Bacteroides engineering toolkit and synthetic biology capabilities position Persephone for enterprise collaborations with biotech partners, CROs, and pharma seeking microbial therapeutics development, enabling strategic alliance and licensing conversations.

Proof and scale With revenue in the mid tens of millions and a focused research base, Persephone is positioned for strategic investors or customers prioritizing evidence-backed microbiome solutions, offering compelling cross-sell of diagnostics, biomarkers, and therapeutic pipelines.